MECHANISMS OF MYOCARDIAL REPERFUSION INJURY--DIABETES
MECHANISMS OF MYOCARDIAL REPERFUSION INJURY--DIABETES
批准号:
6184820
负责人:
DAVID JOSEPH LEFER
金额:
$17.7万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2003-04-30
关键词:
antiinflammatory agents cardiovascular pharmacology cell adhesion molecules diabetes mellitus disease /disorder model gene expression genetically modified animals heart contraction inflammation laboratory mouse model design /development monoclonal antibody myocardial infarction myocardial ischemia /hypoxia neutrophil reperfusion selectins superoxide dismutase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (adapted from the applicant's description): This study is focused
on the neutrophil mediated tissue injury during inflammation of the reperfused
myocardium. The application is revised according to previous review as a R29.
The general premise is that the severity of reperfusion injury appears to be a
greater risk factor in hearts of diabetics than in non-diabetics. Thus, the
central hypothesis is that enhanced neutrophil recruitment and activation is
responsible for greater vulnerability of diabetic myocardium to ischemic/
reperfusion induced tissue necrosis. The applicant proposes to investigate the
molecular mechanisms involved in the inflammatory response that is associated
with reperfusion injury in a db/db strain of diabetic mice and in
streptozotocin treated mice. The experimental plan will utilize an in vivo
model of coronary artery ligation and reperfusion. Monoclonal antibodies will
be used for in vivo quantification of endothelial cell adhesion molecules
(ECAM). The extent of neutrophil accumulation, contractile function, and cell
necrosis will also be examined to assess the vulnerability of the diabetic
heart to ischemia/reperfusion damage. The applicant also intends to evaluate
anti-inflammatory therapies on ECAM expression, leukocyte recruitment, and cell
damage. Several strains of transgenic mice, as knockout models of cytokine or
cell adhesion molecule deficiencies, are also to be tested for the extent of
reperfusion injury following streptozotocin treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hydrogen Sulfide Regulation in Cardioprotection
-
批准号:10391506
-
项目类别:
-
资助金额:$56.2万
-
财政年份:2020
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Hydrogen Sulfide Regulation in Cardioprotection
-
批准号:10162413
-
项目类别:
-
资助金额:$57.6万
-
财政年份:2020
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Hydrogen Sulfide Regulation in Cardioprotection
-
批准号:10610727
-
项目类别:
-
资助金额:$54.7万
-
财政年份:2020
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Endogenous Hydrogen Sulfide Enzymes in Heart Failure
-
批准号:10077584
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2019
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Novel Mitochondrial DNA Repair Enzyme for Heart Failure
-
批准号:9408031
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2017
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Novel antifibrotic small molecules for the treatment of heart failure
-
批准号:9142025
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2016
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Novel Sulfide Releasing Agents for Ischemic Injury
-
批准号:8629076
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2014
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Novel Sulfide Releasing Agents for Ischemic Injury
-
批准号:8889814
-
项目类别:
-
资助金额:$3.11万
-
财政年份:2014
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:8289582
-
项目类别:
-
资助金额:$25.42万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:7900081
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:8835549
-
项目类别:
-
资助金额:$12.94万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:8399050
-
项目类别:
-
资助金额:$8.06万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:7754425
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:8921357
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:8085943
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:8207216
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:7742542
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:7599368
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:8011098
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Mechanism of Myocardial Reperfusion Injury in Diabetes
-
批准号:6998480
-
项目类别:
-
资助金额:$24.23万
-
财政年份:1999
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
海外基金